MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Delcath to pare 20% of its U.S. workforce | Personnel Moves

Delcath to pare 20% of its U.S. workforce | Personnel Moves

By

fired/hired

Queensbury, N.Y.-based Delcath (NSDQ:DCTH) announced last week that it plans to pare its workforce by about 20%, the latest in a series of layoff announcements from the oncology devices maker. This is the 3rd time this year that Delcath has announced imminent layoffs, having announced smaller cuts in April and larger layoffs in January.

The terminations come in the wake of the device maker’s breakdown at the FDA. The FDA’s Oncologic Drugs Advisory Committee in May voted 16-0 that the risks associated with Delcath’s Melblez Kit are higher than its potential benefits for patients with unresectable ocular melanoma metastatic to the liver.

Delcath reported that the cuts are an attempt to "better focus the company’s organizational structure and concentrate financial resources on its clinical development program and European commercialization," noting that European operations will not be impacted by the layoffs.

New of the layoffs was contained in a press release announcing the appointment of William Appling to take over as both the head of R&D and head of global operations. Appling, who has worked for the company for 3 years, will take over for former executive VP of global operations, Harold Mapes, and for former R&D executive Krishna Kandarpa.

"The actions we announced today are designed to further increase our organizational efficiencies with a goal of reducing our expected cash burn in the fourth quarter to approximately 50% of what it was in the 2nd quarter of 2012," Delcath CEO Eamonn Hobbs said in prepared remarks. "Our team continues to be focused on our key strategic priorities in clinical development and European commercialization."

 Hansen Medical legal exec flies the coop
Carolyn Bruguera left Hansen Medical’s (NSDQ:HNSN) legal team June 28. The former VP & general counsel joined the robot surgery systems company in January 2012 following 6 years at Micrus Endovascular Corp.
Read more

 A quick goodbye for NeuroMetrix’s COO
NeuroMetrix (NSDQ:NURO) operations chief Krishnamurthy Balachandran announced his resignation on June 27 and walked out the door 3 days later, according to regulatory filings. Balachandran was the senior VP, general manager of international & COO.
Read more

 New top dog at RF Surgical Systems
RF Surgical Systems pulled John Buhler in as CEO of the company following his role as COO of Natus Medical (NSDQ:BABY). Buhler has also held executive roles at SenoRx and GE (NYSE:GE). Buhler replaced former CEO Kevin Cosens, who was at the helm for 7 years.
Read more

 bioTheranostics adds 2 doctors to its executive team
Cancer diagnostics company bioTheranostics hired Dr. Michael Dugan as CMO and Catherine Schnabel as VP of medical, clinical & regulatory affairs. Dugan was the former CMO of Roche Molecular Systems and previously worked at UCLA. Schnabel’s career spanned executive and research roles at Amylin Pharmaceuticals, Genoptix and Genentech.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • In situ cure technology molds next-gen medical implants
    Innovation in silicone technology has moved beyond defining specific material characteristics and into offering implantable devices that cure and form into shape inside the human body. Benny David, NuSil from Avantor Medical device manufacturers have long relied on highly purified silicone elastomers to fabricate components or entire devices for implantation. Now, recent innovations offer manufacturers… […]
  • How to prevent and troubleshoot short shots in medtech molding
    Deliberate processes to identify and remediate the problem can yield high-quality products and keep patients safe. Shane Vandekerkhof, RJG Short shots are among the most common and visually obvious quality issues most molders face, but they can cause fatal flaws in medical devices. Imagine if a luer lock connector was short. You run the risk… […]
  • AdvaMed launches medtech podcast
    AdvaMed today announced the launch of a new podcast, MedTech POV. AdvaMed president and CEO Scott Whitaker hosts the podcast, which covers the intersection of medtech and policy from a variety of perspectives. Each episode will feature discussions with medtech and healthcare policy leaders on issues that are driving the day — from business to… […]
  • This wearable could signal cytokine storms
    Researchers at the University of Texas at Dallas have developed a sweat sensor that could detect cytokine storms in patients suspected of having COVID-19 and other illnesses. Early on in the pandemic, doctors found that patients who developed a surge of pro-inflammatory immune proteins, called “cytokine storms,” were more often the sickest and at the… […]
  • How to evaluate laser performance for medical device manufacturing
    Laser processing provides automation and efficiencies that help meet FDA regulations and produce superior medical device components. David Locke, ACSYS Lasertechnik US Laser systems have become essential to the production of better-designed medical devices. The precision, repeatability and scale needed to manufacture next-generation medical products rely heavily on the advantages that lasers bring to contract… […]
  • EPA delayed notifying residents of ethylene oxide emissions
    The EPA delayed notifying neighbors of an Illinois medical device sterilization plant of ethylene oxide (EtO) emissions the agency measured in 2018, according to an inspector general’s report released yesterday. The report also says that “leadership” in the agency’s Office of Air and Radiation also failed to conduct public meetings with residents either near the… […]
  • 9 medical devices you should keep an eye out for in 2021
    The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek… […]
  • Greenlight Guru to provide QMS to NIH diagnostics program
    NIH has chosen Greenlight Guru to provide quality management software for its COVID-19 rapid diagnostics program. The agency launched the Rapid Acceleration of Diagnostics (RADx) program in March 2020 to speed the development, commercialization and implementation COVID-19 testing technologies. As the only QMS provider currently available to all projects in the RADx program, Greenlight Guru… […]
  • MicroCare names CFO
    MicroCare (New Britain, Conn.) has announced the appointment of John Stardellis as the company’s new chief financial officer (CFO). Stardellis joins MicroCare with more than 20 years’ experience in a variety of finance, policy and operational leadership roles. Most recently, he served as CFO at i-Health, a division of DSM Nutritional Products. “John’s track record with… […]
  • Mayo Clinic helps launch two new companies for improved diagnostics
    Mayo Clinic announced that it is introducing a new technology platform to support two new companies it has launched. Rochester, Minn.–based Mayo Clinic’s Remote Diagnostics & Management Platform (RDMP) is designed to connect data with new AI algorithms and augment human decision-making within existing clinical workflows, according to a news release. Get the full story… […]
  • Intertek gains FDA nod for premarket device testing
    Intertek has won accreditation under an FDA pilot program for testing laboratories, the company said this week. The accreditation authorizes Intertek’s 12 “medical centers of excellence” to perform premarket testing of devices for the U.S. market. The Accreditation Scheme for Conformity Assessment pilot program is a voluntary program developed to provide increased confidence in testing… […]

Leave a Reply